A detailed history of Parallax Volatility Advisers, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 101,610 shares of NVO stock, worth $11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
101,610
Previous 100 101510.0%
Holding current value
$11 Million
Previous $14,000 86314.29%
% of portfolio
0.02%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $7.55 Million - $9.22 Million
63,434 Added 166.16%
101,610 $12.1 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $3.73 Million - $4.46 Million
30,390 Added 390.32%
38,176 $5.45 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $795,028 - $1.06 Million
7,786 New
7,786 $999,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $143,345 - $158,665
919 New
919 $148,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $366,542 - $449,829
3,847 Added 170.22%
6,107 $608,000
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $233,322 - $275,290
2,260 New
2,260 $252,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $19,489 - $21,487
-306 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $17,854 - $20,721
305 Added 30500.0%
306 $20,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $46 - $52
1 New
1 $0
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $947,227 - $1.08 Million
-20,432 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $356,911 - $405,972
-8,592 Reduced 29.6%
20,432 $941,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $1.36 Million - $1.49 Million
29,024 New
29,024 $1.37 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $4,429 - $5,042
-100 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $4,849 - $5,814
100 New
100 $5,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.